Skip to content

Blog

AOM Infusion Chooses AlayaCare for its Specialty Infusion Technology Solution

AOMCustomerAnnouncementBannerGraphic_1200x628px

Home-based care platform to provide digital benefits and increased efficiencies for specialty infusion provider 

FORT WORTH, TEXAS— January 4, 2023—AOM Infusion, a leading specialty infusion provider, today announced it has signed on with AlayaCare, an end-to-end home-based care technology provider, to enhance and modernize its specialty infusion and nursing operations.  

The home infusion market is expected to expand at a compound annual growth rate of 7.5% from 2022 to 2030 – driven by a growing population experiencing an increase in chronic and auto-immune disorders, coupled with the aftermath of the pandemic. To meet these growing market conditions, AOM Infusion made the choice to integrate AlayaCare to leverage an all-digital, configurable, and intuitive platform that can scale to benefit the company’s growing patient census across the United States. In the search for a new technology provider, the AOM Infusion team were seeking a software that would reinforce the company’s core pillars of being patient-centric and innovative, in addition to boosting everyday operational efficiencies through digitization. 

“What we found unique to AlayaCare as a technology provider is that the platform is designed to grow with our company and growth objectives,” said Keyur Mehta, Chief Operating Officer at AOM Infusion. “The speciality infusion industry is complex, and to successfully establish ourselves in this industry, it was important for us to choose a platform that would adapt to those complexities so we can engage patients and deliver the best care possible. We found the configurability aspect to be the biggest differentiator that would allow us to customize the platform to meet the specific needs of our business,” he added.  

The AlayaCare end-to-end platform enables infusion organizations to manage operations seamlessly, focus less on administrative tasks, and deliver a full continuum of care within one platform. The complete technology solution can oversee the entire patient lifecycle including referrals and intake, scheduling, patient health records, clinical documentation, billing and payroll, reporting, a caregiver mobile app, and a family portal. 

“We applaud the commitment of the AOM Infusion team to innovate, scale, and optimize data-driven operations by moving towards technology of the future,” said Sava Berhané, Senior Vice President of Customer Success at AlayaCare. “As the home infusion industry continues to grow and evolve, working with dedicated organizations like AOM Infusion will only accelerate AlayaCare’s mission of empowering care providers to achieve better health outcomes.” 

###  

About AlayaCare  
AlayaCare offers an end-to-end software platform for governments, home-based care organizations, and community care providers to manage the entire client lifecycle, including needs assessments, care plans, scheduling and visit verification. Combining traditional in-home and virtual care solutions, AlayaCare enables care providers across the world to propel towards innovation and healthcare of the future. For more information,

About AOM Infusion  

AOM Infusion, a leading specialty infusion company, provides intravenous and subcutaneous immunoglobulin (“IVIG and SQIG”), chronic inflammatory and specialized therapies for over 80 different chronic conditions to patients. Therapies are administered and monitored by specially trained infusion nurses and pharmacists. The company also provides national support services, including pharmaceutical care management, referral management, insurance verification and patient education and training. AOM Infusion was founded in 1994 and holds pharmacy licenses in all 50 states. https://aominfusionrx.com/